Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia.
Open Access
- 6 March 1982
- Vol. 284 (6317) , 700-702
- https://doi.org/10.1136/bmj.284.6317.700
Abstract
Nine patients with acute leukaemia developed a complex syndrome of hypocalcaemia and hypomagnesaemia during treatment. These metabolic abnormalities developed rapidly in some patients and gave rise to acute symptoms. Immunoreactive parathormone concentrations in these patients were found to be either absolutely or inappropriately low. Hypomagnesaemia and the action of chemotherapeutic agents, especially adriamycin or cytarabine, or both may have contributed to the pathogenesis of this syndrome.This publication has 9 references indexed in Scilit:
- Immunoreactive calcitonin in leukaemia.BMJ, 1979
- Metabolic Disorders in Acute Myeloid LeukaemiaBritish Journal of Haematology, 1978
- Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapyCancer, 1977
- FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCYClinical Endocrinology, 1976
- A quantitative ultrastructural study of microtubule content and secretory granule accumulation in parathyroid glands of phosphate- and colchicine-treated rats.Journal of Clinical Investigation, 1975
- Secretion and Metabolic Efficacy of Parathyroid Hormone in Patients with Severe HypomagnesemiaJournal of Clinical Endocrinology & Metabolism, 1974
- Regulation of Parathyroid Hormone Secretionin Vitro:Quantitative Aspects of Calcium and Magnesium Ion ControlEndocrinology, 1971
- The influence of magnesium on calcium release from bone in vitroBiochimica et Biophysica Acta (BBA) - General Subjects, 1970
- Response to Vitamin D of Magnesium Deficient Rats.Experimental Biology and Medicine, 1967